Across TCGA pan-cancer cohorts, MIR644A RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR644A’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where MIR644A RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR644A is over-expressed in tumor.
UCEC, BLCA, and STAD are the cancer types where MIR644A tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR644A RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.